Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in a young man with idiopathic non-cystic bronchiectasis and vitamin D3 deficiency.
Respir Med Case Rep
; 31: 101203, 2020.
Article
in English
| MEDLINE | ID: covidwho-733634
ABSTRACT
This is the first reported case, to our knowledge, of co-infection of Bordetella bronchiseptica and SARS-CoV-2 in a young patient with underlying idiopathic bronchiectasis and vitamin D3 deficiency that was treated successfully with a combination therapeutic regime integrating doxycycline, empiric therapies for COVID-19, vitamin D supplementation, and supportive ICU care. Large prospective studies are required to investigate further the role of co-infections in COVID-19 patients with bronchiectasis. Randomized control trials should examine the putative beneficial role of vitamin D supplementation in patients with COVID-19.
Acute respiratory distress syndrome; Bordetella bronchiseptica; COVID-19; CT, computed tomography; ED, emergency department; HFNC, high flow nasal cannula; ICU, intensive care unit; Idiopathic non-cystic bronchiectasis; MV, mechanical ventilation; RT-PCR, Real-Time-Polymerase-Chain-Reaction; SARS-CoV-2 disease, COVID-19; SpO2/FiO2, partial arterial pressure of oxygen to fractional inspired concentration of oxygen; Vitamin D supplementation
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Cohort study
/
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Respir Med Case Rep
Year:
2020
Document Type:
Article
Affiliation country:
J.rmcr.2020.101203
Similar
MEDLINE
...
LILACS
LIS